ArticleNutrition & metabolism2019

Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.

Seyed Ali Jazayeri-Tehrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.